Scientists have discovered how leukemia cells outsmart a leading treatment and may have found a way to stop them. Scientists ...

What if a single test could simultaneously contribute to the diagnosis, characterization, and treatment guidance of childhood ...

First and only therapy FDA approved in both R/R acute myeloid leukemia (AML) with an NPM1 mutation and R/R acute leukemia with a KMT2A ...

The US FDA has approved the supplemental new drug application (sNDA) for revumenib (Revuforj) in the treatment of relapsed or ...

Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast a dominant position in the lucrative oncology space. Oncology or ...

At Corewell Health Helen DeVos Children’s Hospital, leading experts from Corewell Health and Michigan State University research radiopharmaceuticals, an emerging form of cancer therapy.

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, announced ...

Advances in diagnosis, therapy, and supportive care have substantially improved the life expectancy of childhood cancer survivors. This remarkable success, ...

Patients with sickle cell disease and beta-thalassemia treated with exagamglogene autotemcel reported substantial and ...

By combining proteasome inhibitors with Lys05, a drug that impairs autophagy, the team was able to shut down AML’s detour. In ...

Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most ...

A wave of applause, cheers, and even a few joyful catcalls filled The Revaire as champions young and young-in-spirit strutted ...